Physician profile
Robert W Gluck
NPI 1275554933
$4,835.58
in general payments reported to CMS, 2019-2025
33 companies · $467 in 2025
The $467 reported for 2025 was less than what a typical Urology provider received nationally (typical 2025 total: $631).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $830 · 2020: $383 · 2021: $942 · 2022: $741 · 2023: $859 · 2024: $614 · 2025: $467.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,940.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,939.95 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Astellas Pharma US INC | $925.40 | 2019-2024 | Myrbetriq |
| Endo Pharmaceuticals INC. | $823.43 | 2019-2024 | Xiaflex, Aveed, Edex |
| Verity Pharmaceuticals INC. | $314.34 | 2022-2025 | Trelstar |
| Janssen Biotech, INC. | $242.99 | 2019-2024 | Erleada |
| Neotract INC. | $228.96 | 2019-2020 | |
| Endo USA, INC. | $207.83 | 2024-2025 | Xiaflex, Aveed, Edex |
| Abbvie INC. | $190.37 | 2022-2025 | |
| Blue Earth Diagnostics | $189.62 | 2019-2023 | |
| Tolmar Pharmaceuticals, INC. | $168.60 | 2019-2022 | |
| Olympus America INC. | $164.92 | 2021-2025 | Itind System |
| Pfizer INC. | $151.52 | 2019-2025 | |
| Tolmar, INC. | $135.01 | 2023-2025 | Eligard |
| Abbott Laboratories | $117.67 | 2023 | Proclaim |
| Urogen Pharma, INC. | $111.48 | 2022-2025 | Jelmyto |
| Ferring Pharmaceuticals INC. | $95.66 | 2019-2024 | Adstiladrin |
Show all 33 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Progenics Pharmaceuticals, INC. | $93.78 | 2022-2023 | Pylarify |
| Merck Sharp & Dohme LLC | $85.28 | 2021-2022 | |
| Rochester Medical Corporation | $79.63 | 2019-2020 | |
| Myriad Genetic Laboratories, INC. | $78.63 | 2021-2023 | Prolaris |
| Boston Scientific Corporation | $69.40 | 2019-2023 | Varithena Administration Pack |
| Urovant Sciences INC | $63.09 | 2021 | |
| 180 Medical, INC. | $49.83 | 2022-2023 | Gentlecath |
| Bayer Healthcare Pharmaceuticals INC. | $31.30 | 2021 | |
| Acerus Pharmaceuticals Corporation | $30.28 | 2022 | |
| Laborie Medical Technologies Corp. | $26.32 | 2025 | Optilume Bph Drug Coated Balloon Catheter |
| Medtronic, INC. | $22.65 | 2024 | Interstim |
| Myovant Sciences INC. | $22.33 | 2022 | |
| C. R. Bard, INC. & Subsidiaries | $22.22 | 2019 | |
| Azurity Pharmaceuticals, INC. | $21.23 | 2025 | Azmiro |
| Allergan, INC. | $20.94 | 2019 | |
| Clarus Therapeutics INC. | $19.29 | 2021 | |
| Axonics, INC. | $17.01 | 2024 | Bulkamid |
| Coloplast Corp | $14.57 | 2021 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Robert Gluck listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.